Dry Eye Disease Treatment Options
Dry eye disease (DED) affects millions of Americans, yet lacks effective treatment options, resulting in high discontinuation rates.
According to an abstract presented at the 2025 Academy of Managed Care Pharmacy (AMCP) Nexus Conference, high discontinuation rates and limited therapy switching indicate a need for more effective and diverse treatment options.
At least 75% of dry eye disease patients discontinue their treatment, with just 10.8% moving to a second line of therapy.
The abstract, titled ‘Real-world prescription drug treatment patterns in patients with dry eye disease,’ was co-led by Tony Okoro, Pharm.D., M.P.H., and Ramaa Nathan, Ph.D.
Author's summary: Dry eye disease lacks effective treatments.
More News
- SNAP Benefits to Halt on Nov 1 as Shutdown Threatens to Deepen Food Crisis in Sacramento
- Top batters dismissed for zero as Zimbabwe suffer disappointing T-20 loss to Afghanistan – Nehanda Radio
- From MRI to Ozempic: breakthroughs that show why fundamental research must be protected
- This New Spy Thriller Series Took Over Netflix and Hit #3 Overnight
- The Sopranos Almost Had a Disastrously Obvious Main Theme Song
- Microsoft Azure is down, affecting 365, Xbox, Minecraft, and others | TechCrunch
- The Sixers appeared to finally run out of energy. Then, Adem Bona happened
- Lorient v PSG: Confirmed line-ups as Ballon d'Or winner Dembele returns
- Roma v Parma: here are the official line-ups
- Xbox Network and Minecraft Go Down After Major Microsoft Azure Outage | iPhone in Canada